Ryotaro Bouchi Selected Research

Ryotaro Bouchi Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 05/2024 - 12/2011
5	COVID-19 08/2023 - 06/2022
5	Neoplasms (Cancer) 02/2023 - 12/2015
4	Hyperglycemia 10/2023 - 11/2017
4	Inflammation (Inflammations) 03/2021 - 01/2016
4	Adenoma (Adenomas) 10/2017 - 08/2015
3	Hypoglycemia (Reactive Hypoglycemia) 02/2022 - 11/2017
2	Diabetes Mellitus 12/2023 - 04/2023
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2023 - 11/2017
2	Hyperaldosteronism (Conn Syndrome) 09/2018 - 12/2015
2	Body Weight (Weight, Body) 08/2017 - 01/2017
2	Insulin Resistance 08/2017 - 01/2017
2	Albuminuria 03/2017 - 12/2011
2	Diabetic Nephropathies (Diabetic Nephropathy) 03/2012 - 12/2011
1	Obesity 12/2023
1	Weight Gain 12/2023
1	Asthma (Bronchial Asthma) 12/2023
1	Fatty Liver 12/2023
1	Dysbiosis 10/2023
1	Non-alcoholic Fatty Liver Disease 10/2023
1	HIV Infections (HIV Infection) 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 03/2023
1	Infections 03/2023
1	Graves Disease (Basedow Disease) 03/2023
1	Paraganglioma (Paragangliomas) 02/2023
1	Pheochromocytoma 02/2023
1	Hemiplegia (Spastic Hemiplegia) 02/2022
1	Reperfusion Injury 02/2022
1	Disease Progression 11/2021
1	Weight Loss (Weight Reduction) 03/2018
1	Hyperinsulinism (Hyperinsulinemia) 03/2018
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Abdominal Obesity 08/2017
1	Sarcopenia 01/2017
1	Adrenocortical Adenoma (Disease, Conn's) 06/2016
1	Diabetes Complications 01/2016
1	Spondylitis 01/2016
1	Carcinogenesis 08/2015

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2017
8	Insulin (Novolin)FDA Link 10/2023 - 01/2016
5	AldosteroneIBA 09/2018 - 08/2015
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2023 - 06/2022
3	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2021 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 04/2023 - 06/2022
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2015
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2017 - 06/2016
2	SodiumIBA 08/2017 - 01/2017
2	HDL CholesterolIBA 08/2017 - 03/2012
2	LeptinIBA 08/2017 - 12/2011
2	Triglycerides (Triacylglycerol)IBA 08/2017 - 01/2017
2	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 08/2017 - 01/2017
2	EnzymesIBA 06/2016 - 01/2016
2	LipidsIBA 06/2016 - 03/2012
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2015 - 08/2015
1	AntibodiesIBA 12/2023
1	tezepelumabIBA 12/2023
1	Thymic Stromal LymphopoietinIBA 12/2023
1	Nonesterified Fatty Acids (NEFA)IBA 12/2023
1	Streptozocin (Streptozotocin)FDA Link 10/2023
1	Antimicrobial PeptidesIBA 10/2023
1	PhlorhizinIBA 10/2023
1	Insulin ReceptorIBA 10/2023
1	AcidsIBA 03/2023
1	Carboxy-LyasesIBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 03/2023
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 03/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 02/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	CarbohydratesIBA 01/2023
1	AntigensIBA 01/2023
1	Methylprednisolone FDA LinkGeneric 12/2022
1	GlucocorticoidsIBA 12/2022
1	Hormones (Hormone)IBA 11/2021
1	dapagliflozinIBA 03/2021
1	Sodium-Glucose Transport ProteinsIBA 03/2021
1	Indicators and Reagents (Reagents)IBA 09/2018
1	Eplerenone (Inspra)FDA LinkGeneric 09/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 11/2017
1	RNA (Ribonucleic Acid)IBA 10/2017
1	ipragliflozinIBA 08/2017
1	Liraglutide FDA Link 03/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	CytokinesIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Codon (Codons)IBA 12/2015

Therapy/Procedure

5	Glycemic Control 05/2024 - 06/2022
4	Therapeutics 12/2023 - 11/2017
3	Drug Therapy (Chemotherapy) 10/2023 - 01/2023
2	Adrenalectomy 02/2023 - 09/2018
1	Bronchial Thermoplasty 12/2023
1	Laparotomy 02/2023
1	Pancreatectomy 11/2017
1	Conservative Treatment 01/2016